2020
DOI: 10.31226/osf.io/n2dup
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Ozonetherapy: a multirole weapon, topical pathway against SARS-COV-2

Abstract: COVID-19 is the respiratory disease caused by the new coronavirus SARS-CoV-2 and is characterized by clinical manifestations ranging from mild, flu-like symptoms to severe respiratory and multi-organ failure. Patients with more severe symptoms may require intensive care treatments and face a high risk of mortality. COVID 19 is characterized by an abnormal inflammatory response similar to a cytokine storm, which is associated with endothelial dysfunction and microvascular complications. To date, no specific tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…O 3 is a strong oxidizing agent and can thus be used to disinfect viral infection [71]. Ozonation could result in a decrease in viral load [72].…”
Section: Ozone Therapymentioning
confidence: 99%
“…O 3 is a strong oxidizing agent and can thus be used to disinfect viral infection [71]. Ozonation could result in a decrease in viral load [72].…”
Section: Ozone Therapymentioning
confidence: 99%
“… 56 Therefore, SARS-CoV-2 could potentially be inactivated by ozone-mediated oxidation during the viremic phase (if administered early via auto-hemo-infusion) and at the level of the colonized nasopharyngeal mucosa of healthy carriers through topic formulations. 57 …”
Section: O Zone In Covid-19mentioning
confidence: 99%
“…Finally, in particular cases, the use of the ozone-dilution technique in physiological solution and its infusion could also be evaluated and, in the future, the possibility of using ozone therapy with endonasal insufflation as a substitute for the vaccine could be evaluated [43].…”
Section: Sars-cov-2 and Intestinementioning
confidence: 99%